Physician profile
Christopher Schaefer
NPI 1679780407
$4,353.42
in general payments reported to CMS, 2019-2025
37 companies · $485 in 2025
The $485 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $980 · 2020: $668 · 2021: $1,081 · 2022: $619 · 2023: $285 · 2024: $235 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,005.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $865.08 | 2019-2025 | Xtandi |
| Myriad Genetic Laboratories, INC. | $403.39 | 2020-2025 | Prolaris |
| Antares Pharma, INC. | $305.11 | 2019-2022 | |
| Janssen Biotech, INC. | $232.58 | 2019-2023 | Remicade, Simponi, Simponi Aria |
| Neotract INC. | $187.01 | 2019 | |
| Dendreon Pharmaceuticals LLC | $165.08 | 2019-2025 | Provenge |
| Calyxo, INC. | $161.81 | 2025 | Cvac Aspiration System |
| Tolmar Pharmaceuticals, INC. | $153.24 | 2019-2022 | |
| Abbvie INC. | $151.63 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $137.73 | 2019-2021 | |
| Boston Scientific Corporation | $132.18 | 2019-2025 | Axonics |
| Sumitomo Pharma America, INC. | $129.20 | 2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $124.99 | 2021 | |
| Pfizer INC. | $114.30 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $113.52 | 2019-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $105.54 | 2019 | |
| Medtronic, INC. | $102.59 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $99.45 | 2020 | |
| Coloplast Corp | $72.66 | 2020-2024 | Speedicath |
| Clarus Therapeutics INC. | $65.18 | 2021 | |
| Blue Earth Diagnostics | $57.56 | 2019-2021 | |
| Aytu Biopharma, INC. | $57.04 | 2019 | |
| Ferring Pharmaceuticals INC. | $54.51 | 2019-2025 | Adstiladrin |
| Alnylam Pharmaceuticals INC. | $49.18 | 2020-2021 | |
| Mission Pharmacal Company | $48.24 | 2019-2022 | |
| Myovant Sciences INC. | $35.31 | 2021 | |
| Merck Sharp & Dohme LLC | $33.48 | 2020-2021 | |
| Teleflex LLC | $30.46 | 2021-2024 | Urolift |
| Metuchen Pharmaceuticals | $29.63 | 2019-2020 | |
| 180 Medical, INC. | $24.97 | 2021 | |
| Acerus Pharmaceuticals Corporation | $23.59 | 2020 | |
| Sun Pharmaceutical Industries INC. | $17.39 | 2020 | |
| Medtronic USA, INC. | $17.30 | 2020 | |
| Allergan, INC. | $14.67 | 2020 | |
| Avation Medical, INC. | $14.11 | 2025 | Vivally System |
| Rochester Medical Corporation | $12.24 | 2022 | |
| Axonics, INC. | $11.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.